22 results on '"Kaufmann, Andreas M."'
Search Results
2. German evidence and consensus-based (S3) guideline: Vaccination recommendations for the prevention of HPV-associated lesions
3. Evidence for disseminated tumor cells in lymphatic vessels afferent to sentinel lymph nodes in patients diagnosed with cervical cancer
4. Evidenz‐ und konsensbasierte (S3) Leitlinie: Impfprävention HPV‐assoziierter Neoplasien
5. German evidence and consensus‐based (S3) guideline: Vaccination recommendations for the prevention of HPV‐associated lesions
6. Population‐based human papillomavirus infection and genotype distribution among women in rural areas of South Central Ethiopia
7. Clinical performance of the HPV DNA Array genotyping assay in detection of CIN2+ lesions with BS GP5+/6+ MPG Luminex tested cervical samples
8. Ten-year immune persistence and safety of the HPV-16/18 AS04-adjuvanted vaccine in females vaccinated at 15-55 years of age
9. Human papillomavirus E7 protein detection as a method of triage to colposcopy of HPV positive women, in comparison to genotyping and cytology. Final results of the PIPAVIR study
10. A phase 1/2a study to test the safety and immunogenicity of a p16INK4apeptide vaccine in patients with advanced human papillomavirus-associated cancers
11. Epigenetic inactivation of TRAIL decoy receptors at 8p12-21.3 commonly deleted region confers sensitivity to Apo2L/trail-Cisplatin combination therapy in cervical cancer
12. Identification of promiscuous HPV16-derived T helper cell epitopes for therapeutic HPV vaccine design
13. Epidermal growth factor receptor expression affects the efficacy of the combined application of saponin and a targeted toxin on human cervical carcinoma cells
14. Protocadherin PCDH10, involved in tumor progression, is a frequent and early target of promoter hypermethylation in cervical cancer
15. Enhancement of immunogenicity of a therapeutic cervical cancer DNA-based vaccine by co-application of sequence-optimized genetic adjuvants
16. Regulatory (FOXP3+) T cells as target for immune therapy of cervical intraepithelial neoplasia and cervical cancer
17. Identification of copy number gain and overexpressed genes on chromosome arm 20q by an integrative genomic approach in cervical cancer: Potential role in progression
18. Vaccination trial with HPV16 L1E7 chimeric virus‐like particles in women suffering from high grade cervical intraepithelial neoplasia (CIN 2/3)
19. Enhancement of Immunogenicity of Jeg3 Cells by Ectopic Expression of HLA‐A*0201 and CD80
20. Identification of a naturally processed HLA‐A*0201 HPV18 E7 T cell epitope by tumor cell mediated in vitro vaccination
21. Enhancement of immunogenicity of JEG‐3 Cells by ectopic expression of HLA‐A*0201 and CD80
22. A phase 1/2a study to test the safety and immunogenicity of a p16(INK4a) peptide vaccine in patients with advanced human papillomavirus-associated cancers.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.